It would be simply naive to expect a positive reaction from other countries to the registration of the Russian vaccine against coronavirus.
This is a direct struggle specifically for money. There could be no other reaction. It would be naive to expect that a rather serious competitive product will be received with applause. After all, specific people, specific firms are losing many billions of dollars, well, what kind of reaction do you want to see? The reaction is completely normal. It’s like a stick being shoved into an anthill.
Reservations and criticism of the Sputnik V vaccine are caused by the fact that Russia hasn’t completed large trials to test the vaccine’s safety and efficacy, and rolling out an inadequately vetted vaccine could endanger people who receive it.
The World Health Organisation expressed some reservations about the procedure followed by Russia, initiating talks with Russian authorities about undertaking a review of the vaccine but refusing to endorse it right away. On August 2020, the WHO published a landscape of COVID-19 candidate vaccines, which considered the Russian project developed by Gamaleya Research Institute as being in Phase 1 of clinical testing.